{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:43:09Z","timestamp":1794534189925,"version":"4.9.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68132-2","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:52:05Z","timestamp":1767804725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-7241","authenticated-orcid":false,"given":"Pratishtha","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranit","family":"D\u2019Rozario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidisha","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swadhin","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deblina","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah J.","family":"Tannir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessalyn","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-055X","authenticated-orcid":false,"given":"Padmanee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir","family":"Akdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3268-514X","authenticated-orcid":false,"given":"Abhinav K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-9688","authenticated-orcid":false,"given":"Byron Hing Lung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-4503","authenticated-orcid":false,"given":"Sangeeta","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"68132_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J Clin 75, 10\u201345 (2025).","journal-title":"CA Cancer J Clin"},{"key":"68132_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","volume":"16","author":"C Alifrangis","year":"2019","unstructured":"Alifrangis, C., McGovern, U., Freeman, A., Powles, T. & Linch, M. Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol 16, 465\u2013483 (2019).","journal-title":"Nat Rev Urol"},{"key":"68132_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrurol.2017.179","volume":"15","author":"KM Felsenstein","year":"2018","unstructured":"Felsenstein, K. M. & Theodorescu, D. Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. Nat Rev Urol 15, 92\u2013111 (2018).","journal-title":"Nat Rev Urol"},{"key":"68132_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ncpuro0318","volume":"2","author":"EM Wolff","year":"2005","unstructured":"Wolff, E. M., Liang, G. & Jones, P. A. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2, 502\u2013510 (2005).","journal-title":"Nat Clin Pract Urol"},{"key":"68132_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171, 540\u2013556.e525 (2017).","journal-title":"Cell"},{"key":"68132_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11, 726\u2013734 (2011).","journal-title":"Nat Rev Cancer"},{"key":"68132_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E. & Theodorescu, D. Advances in bladder cancer biology and therapy. Nat Rev Cancer 21, 104\u2013121 (2021).","journal-title":"Nat Rev Cancer"},{"key":"68132_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/0008-5472.CAN-22-1444","volume":"83","author":"H Qiu","year":"2023","unstructured":"Qiu, H. et al. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer. Cancer Res 83, 814\u2013829 (2023).","journal-title":"Cancer Res"},{"key":"68132_CR9","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda, P. S. et al. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci USA 110, 17426\u201317431 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"68132_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrurol.2017.11","volume":"14","author":"AP Glaser","year":"2017","unstructured":"Glaser, A. P., Fantini, D., Shilatifard, A., Schaeffer, E. M. & Meeks, J. J. The evolving genomic landscape of urothelial carcinoma. Nat Rev Urol 14, 215\u2013229 (2017).","journal-title":"Nat Rev Urol"},{"key":"68132_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger, K. et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731\u2013734 (2007).","journal-title":"Nature"},{"key":"68132_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature06192","volume":"449","author":"F Lan","year":"2007","unstructured":"Lan, F. et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449, 689\u2013694 (2007).","journal-title":"Nature"},{"key":"68132_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet 52, 891\u2013897 (2020).","journal-title":"Nat Genet"},{"key":"68132_CR14","doi-asserted-by":"publisher","first-page":"11787","DOI":"10.1093\/nar\/gkab984","volume":"49","author":"T Paulsen","year":"2021","unstructured":"Paulsen, T. et al. MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damage. Nucleic Acids Res 49, 11787\u201311799 (2021).","journal-title":"Nucleic Acids Res"},{"key":"68132_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1158\/2159-8290.CD-23-1117","volume":"15","author":"JC Rose","year":"2025","unstructured":"Rose, J. C. et al. Disparate Pathways for Extrachromosomal DNA Biogenesis and Genomic DNA Repair. Cancer Discov 15, 69\u201382 (2025).","journal-title":"Cancer Discov"},{"key":"68132_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41418-021-00875-z","volume":"29","author":"C Prieto-Garcia","year":"2022","unstructured":"Prieto-Garcia, C. et al. Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway. Cell Death Differ 29, 568\u2013584 (2022).","journal-title":"Cell Death Differ"},{"key":"68132_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07265-6","volume":"15","author":"A Hira","year":"2024","unstructured":"Hira, A., Zhang, J. & Kadakia, M. P. TIP60 enhances cisplatin resistance via regulating DeltaNp63alpha acetylation in SCC. Cell Death Dis 15, 877 (2024).","journal-title":"Cell Death Dis"},{"key":"68132_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/ijms20020270","volume":"20","author":"MG Mendoza-Rodriguez","year":"2019","unstructured":"Mendoza-Rodriguez, M. G. et al. IL-1beta Inflammatory Cytokine-Induced TP63 Isoform \u2206NP63alpha Signaling Cascade Contributes to Cisplatin Resistance in Human Breast Cancer Cells. Int J Mol Sci 20, 270 (2019).","journal-title":"Int J Mol Sci"},{"key":"68132_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/1541-7786.MCR-18-0451","volume":"17","author":"C Breed","year":"2019","unstructured":"Breed, C. et al. Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel. Mol Cancer Res 17, 741\u2013750 (2019).","journal-title":"Mol Cancer Res"},{"key":"68132_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1074\/mcp.M500140-MCP200","volume":"5","author":"JJ Stewart","year":"2006","unstructured":"Stewart, J. J. et al. Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5, 433\u2013443 (2006).","journal-title":"Mol Cell Proteomics"},{"key":"68132_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07564-6","volume":"16","author":"W Zhu","year":"2025","unstructured":"Zhu, W. et al. GLI2 inhibits cisplatin sensitivity in gastric cancer through DEC1\/ZEB1 mediated EMT. Cell Death Dis 16, 204 (2025).","journal-title":"Cell Death Dis"},{"key":"68132_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.794959","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Hedgehog-Gli2 Signaling Promotes Chemoresistance in Ovarian Cancer Cells by Regulating MDR1. Front Oncol 11, 794959 (2021).","journal-title":"Front Oncol"},{"key":"68132_CR23","doi-asserted-by":"publisher","first-page":"E5990","DOI":"10.1073\/pnas.1801348115","volume":"115","author":"YA Tang","year":"2018","unstructured":"Tang, Y. A. et al. Hypoxic tumor microenvironment activates GLI2 via HIF-1alpha and TGF-beta2 to promote chemoresistance in colorectal cancer. Proc Natl Acad Sci USA 115, E5990\u2013E5999 (2018).","journal-title":"Proc Natl Acad Sci USA"},{"key":"68132_CR24","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/s41388-018-0553-0","volume":"38","author":"Y Jia","year":"2019","unstructured":"Jia, Y. et al. The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. Oncogene 38, 1764\u20131777 (2019).","journal-title":"Oncogene"},{"key":"68132_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-5793(99)01744-5","volume":"465","author":"Y Nishii","year":"2000","unstructured":"Nishii, Y. et al. CROP\/Luc7A, a novel serine\/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line. FEBS Lett 465, 153\u2013156 (2000).","journal-title":"FEBS Lett"},{"key":"68132_CR26","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.3390\/cimb46050247","volume":"46","author":"Y Hou","year":"2024","unstructured":"Hou, Y. et al. Proteomics Identifies LUC7L3 as a Prognostic Biomarker for Hepatocellular Carcinoma. Curr Issues Mol Biol 46, 4004\u20134020 (2024).","journal-title":"Curr Issues Mol Biol"},{"key":"68132_CR27","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang, D. et al. A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40, 6395\u20136405 (2021).","journal-title":"Oncogene"},{"key":"68132_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10495-024-02027-3","volume":"30","author":"G Qi","year":"2025","unstructured":"Qi, G. et al. SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT\/mTOR\/Autophagy pathway. Apoptosis 30, 83\u201398 (2025).","journal-title":"Apoptosis"},{"key":"68132_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/hed.26961","volume":"44","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Pan, H., He, Y., Hu, C. & Gu, Y. Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma. Head Neck 44, 591\u2013605 (2022).","journal-title":"Head Neck"},{"key":"68132_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116798","volume":"235","author":"A Zou","year":"2019","unstructured":"Zou, A. et al. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway. Life Sci 235, 116798 (2019).","journal-title":"Life Sci"},{"key":"68132_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111859","volume":"41","author":"TN Clinton","year":"2022","unstructured":"Clinton, T. N. et al. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. Cell Rep 41, 111859 (2022).","journal-title":"Cell Rep"},{"key":"68132_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2018.09.002","volume":"75","author":"EJ Pietzak","year":"2019","unstructured":"Pietzak, E. J. et al. Genomic Differences Between \u201cPrimary\u201d and \u201cSecondary\u201d Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. Eur Urol 75, 231\u2013239 (2019).","journal-title":"Eur Urol"},{"key":"68132_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04627-w","volume":"13","author":"C Lin","year":"2022","unstructured":"Lin, C. et al. Encoding gene RAB3B exists in linear chromosomal and circular extrachromosomal DNA and contributes to cisplatin resistance of hypopharyngeal squamous cell carcinoma via inducing autophagy. Cell Death Dis 13, 171 (2022).","journal-title":"Cell Death Dis"},{"key":"68132_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1158\/2159-8290.CD-23-0656","volume":"14","author":"S Pal Choudhuri","year":"2024","unstructured":"Pal Choudhuri, S. et al. Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs. Cancer Discov 14, 804\u2013827 (2024).","journal-title":"Cancer Discov"},{"key":"68132_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-024-07955-3","volume":"635","author":"DD Nguyen","year":"2024","unstructured":"Nguyen, D. D. et al. The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution. Nature 635, 219\u2013228 (2024).","journal-title":"Nature"},{"key":"68132_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.646390","volume":"9","author":"H Tang","year":"2021","unstructured":"Tang, H., Chen, J., Han, X., Feng, Y. & Wang, F. Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance. Front Cell Dev Biol 9, 646390 (2021).","journal-title":"Front Cell Dev Biol"},{"key":"68132_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00280-018-3759-5","volume":"83","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines. Cancer Chemother Pharmacol 83, 603\u2013613 (2019).","journal-title":"Cancer Chemother Pharmacol"},{"key":"68132_CR38","first-page":"249","volume":"1","author":"SC Hsu","year":"2009","unstructured":"Hsu, S. C., Miller, S. A., Wang, Y. & Hung, M. C. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 1, 249\u2013258 (2009).","journal-title":"Am J Transl Res"},{"key":"68132_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"68132_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51, 202\u2013206 (2019).","journal-title":"Nat Genet"},{"key":"68132_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13915-7","volume":"11","author":"K von Loga","year":"2020","unstructured":"von Loga, K. et al. Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nat Commun 11, 139 (2020).","journal-title":"Nat Commun"},{"key":"68132_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33980-9","volume":"13","author":"JS Damrauer","year":"2022","unstructured":"Damrauer, J. S. et al. Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer. Nat Commun 13, 6658 (2022).","journal-title":"Nat Commun"},{"key":"68132_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/71643","volume":"24","author":"SM Lipkin","year":"2000","unstructured":"Lipkin, S. M. et al. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet 24, 27\u201335 (2000).","journal-title":"Nat Genet"},{"key":"68132_CR44","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1158\/2159-8290.CD-20-0790","volume":"11","author":"J Chung","year":"2021","unstructured":"Chung, J. et al. DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. Cancer Discov 11, 1176\u20131191 (2021).","journal-title":"Cancer Discov"},{"key":"68132_CR45","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","volume":"33","author":"M Maio","year":"2022","unstructured":"Maio, M. et al. Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study. Ann Oncol 33, 929\u2013938 (2022).","journal-title":"Ann Oncol"},{"key":"68132_CR46","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMe2031294","volume":"383","author":"A Grothey","year":"2020","unstructured":"Grothey, A. Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care. N Engl J Med 383, 2283\u20132285 (2020).","journal-title":"N Engl J Med"},{"key":"68132_CR47","first-page":"3087","volume":"56","author":"S Aebi","year":"1996","unstructured":"Aebi, S. et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56, 3087\u20133090 (1996).","journal-title":"Cancer Res"},{"key":"68132_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54065-6","volume":"9","author":"MM Silva","year":"2019","unstructured":"Silva, M. M., Rocha, C. R. R., Kinker, G. S., Pelegrini, A. L. & Menck, C. F. M. The balance between NRF2\/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. Sci Rep 9, 17639 (2019).","journal-title":"Sci Rep"},{"key":"68132_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dnarep.2015.10.003","volume":"35","author":"A Sawant","year":"2015","unstructured":"Sawant, A., Kothandapani, A., Zhitkovich, A., Sobol, R. W. & Patrick, S. M. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links. DNA Repair (Amst) 35, 126\u2013136 (2015).","journal-title":"DNA Repair (Amst)"},{"key":"68132_CR50","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/cancers15143639","volume":"15","author":"V Tuninetti","year":"2023","unstructured":"Tuninetti, V. et al. Retrospective Analysis of the Correlation of MSI-h\/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience. Cancers (Basel) 15, 3639 (2023).","journal-title":"Cancers (Basel)"},{"key":"68132_CR51","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo, L. J. & Yang, L. X. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 22, 305\u2013309 (2008).","journal-title":"In Vivo"},{"key":"68132_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive, P. L. & Banath, J. P. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1, 23\u201329 (2006).","journal-title":"Nat Protoc"},{"key":"68132_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tig.2020.06.018","volume":"36","author":"O Chatzidoukaki","year":"2020","unstructured":"Chatzidoukaki, O., Goulielmaki, E., Schumacher, B. & Garinis, G. A. DNA Damage Response and Metabolic Reprogramming in Health and Disease. Trends Genet 36, 777\u2013791 (2020).","journal-title":"Trends Genet"},{"key":"68132_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12640-5","volume":"10","author":"C Milanese","year":"2019","unstructured":"Milanese, C. et al. DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering. Nat Commun 10, 4887 (2019).","journal-title":"Nat Commun"},{"key":"68132_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633305","volume":"9","author":"T Sobanski","year":"2021","unstructured":"Sobanski, T. et al. Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy. Front Cell Dev Biol 9, 633305 (2021).","journal-title":"Front Cell Dev Biol"},{"key":"68132_CR56","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/cdd.2016.39","volume":"23","author":"DS Matassa","year":"2016","unstructured":"Matassa, D. S. et al. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ 23, 1542\u20131554 (2016).","journal-title":"Cell Death Differ"},{"key":"68132_CR57","first-page":"1055","volume":"53","author":"Y Xu","year":"2018","unstructured":"Xu, Y. et al. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells. Int J Oncol 53, 1055\u20131068 (2018).","journal-title":"Int J Oncol"},{"key":"68132_CR58","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino, M., Rathmell, J. C., Galluzzi, L. & Vanpouille-Box, C. Cancer cell metabolism and antitumour immunity. Nat Rev Immunol 24, 654\u2013669 (2024).","journal-title":"Nat Rev Immunol"},{"key":"68132_CR59","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"68132_CR60","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massague, J. Transforming Growth Factor-beta Signaling in Immunity and Cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"68132_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"68132_CR62","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri, D. et al. Histone lactylation drives CD8(+) T cell metabolism and function. Nat Immunol 25, 2140\u20132151 (2024).","journal-title":"Nat Immunol"},{"key":"68132_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot, L. et al. Bladder cancer. Nat Rev Dis Primers 9, 58 (2023).","journal-title":"Nat Rev Dis Primers"},{"key":"68132_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08372-9","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Significance of KDM6A mutation in bladder cancer immune escape. BMC Cancer 21, 635 (2021).","journal-title":"BMC Cancer"},{"key":"68132_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45479-6","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer. Nature communications 15, 1515 (2024).","journal-title":"Nature communications"},{"key":"68132_CR66","unstructured":"Lv, W. et al. Spatial-Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and Tumor-Immune Microenvironment. Cancer Discov. 15, 1225\u20131246 (2025)."},{"key":"68132_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey, C. et al. Origins and impact of extrachromosomal DNA. Nature 635, 193\u2013200 (2024).","journal-title":"Nature"},{"key":"68132_CR68","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1158\/2159-8290.CD-24-0830","volume":"14","author":"S Su","year":"2024","unstructured":"Su, S. Beneath the Surface: Neoantigens beyond Chromosomal DNA Mutations. Cancer Discov 14, 2066\u20132070 (2024).","journal-title":"Cancer Discov"},{"key":"68132_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.devcel.2009.08.005","volume":"17","author":"RC Akkers","year":"2009","unstructured":"Akkers, R. C. et al. A hierarchy of H3K4me3 and H3K27me3 acquisition in spatial gene regulation in Xenopus embryos. Dev Cell 17, 425\u2013434 (2009).","journal-title":"Dev Cell"},{"key":"68132_CR70","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/imm.12100","volume":"139","author":"PS Lim","year":"2013","unstructured":"Lim, P. S., Li, J., Holloway, A. F. & Rao, S. Epigenetic regulation of inducible gene expression in the immune system. Immunology 139, 285\u2013293 (2013).","journal-title":"Immunology"},{"key":"68132_CR71","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41388-020-01449-y","volume":"39","author":"X Leng","year":"2020","unstructured":"Leng, X. et al. Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3. Oncogene 39, 6468\u20136479 (2020).","journal-title":"Oncogene"},{"key":"68132_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101778","volume":"37","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Qi, Y., Shen, J. & Chen, Z. Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells. Transl Oncol 37, 101778 (2023).","journal-title":"Transl Oncol"},{"key":"68132_CR73","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41375-023-01833-z","volume":"37","author":"LD Boila","year":"2023","unstructured":"Boila, L. D. et al. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition. Leukemia 37, 751\u2013764 (2023).","journal-title":"Leukemia"},{"key":"68132_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/annonc\/mdt384","volume":"25","author":"JM Lee","year":"2014","unstructured":"Lee, J. M., Ledermann, J. A. & Kohn, E. C. PARP Inhibitors for BRCA1\/2 mutation-associated and BRCA-like malignancies. Ann Oncol 25, 32\u201340 (2014).","journal-title":"Ann Oncol"},{"key":"68132_CR75","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"68132_CR76","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41594-018-0092-y","volume":"25","author":"EM Goellner","year":"2018","unstructured":"Goellner, E. M. et al. Identification of Exo1-Msh2 interaction motifs in DNA mismatch repair and new Msh2-binding partners. Nat Struct Mol Biol 25, 650\u2013659 (2018).","journal-title":"Nat Struct Mol Biol"},{"key":"68132_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59470-2","volume":"16","author":"M Roy","year":"2025","unstructured":"Roy, M. et al. EXO1 promotes the meiotic MLH1-MLH3 endonuclease through conserved interactions with MLH1, MSH4 and DNA. Nat Commun 16, 4141 (2025).","journal-title":"Nat Commun"},{"key":"68132_CR78","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41420-021-00633-7","volume":"7","author":"S Yan","year":"2021","unstructured":"Yan, S. et al. ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1\/EXO1. Cell Death Discov 7, 260 (2021).","journal-title":"Cell Death Discov"},{"key":"68132_CR79","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/nar\/gkp1164","volume":"38","author":"E Bolderson","year":"2010","unstructured":"Bolderson, E. et al. Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic Acids Res 38, 1821\u20131831 (2010).","journal-title":"Nucleic Acids Res"},{"key":"68132_CR80","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1073\/pnas.1521597113","volume":"113","author":"G Lu","year":"2016","unstructured":"Lu, G. et al. Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining. Proc Natl Acad Sci USA 113, 1256\u20131260 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"68132_CR81","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/neuonc\/noac231","volume":"25","author":"R Yang","year":"2023","unstructured":"Yang, R. et al. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro Oncol 25, 635\u2013647 (2023).","journal-title":"Neuro Oncol"},{"key":"68132_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep 39, 110986 (2022).","journal-title":"Cell Rep"},{"key":"68132_CR83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai, S. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell 40, 201\u2013218.e209 (2022).","journal-title":"Cancer Cell"},{"key":"68132_CR84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat Biotechnol 29, 24\u201326 (2011).","journal-title":"Nat Biotechnol"},{"key":"68132_CR85","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14, 178\u2013192 (2013).","journal-title":"Brief Bioinform"},{"key":"68132_CR86","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"68132_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3160-3","volume":"20","author":"I Prada-Luengo","year":"2019","unstructured":"Prada-Luengo, I., Krogh, A., Maretty, L. & Regenberg, B. Sensitive detection of circular DNAs at single-nucleotide resolution using guided realignment of partially aligned reads. BMC Bioinformatics 20, 663 (2019).","journal-title":"BMC Bioinformatics"},{"key":"68132_CR88","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357\u2013359 (2012).","journal-title":"Nat Methods"},{"key":"68132_CR89","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust, G. G. & Hall, I. M. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics 30, 2503\u20132505 (2014).","journal-title":"Bioinformatics"},{"key":"68132_CR90","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).","journal-title":"Bioinformatics"},{"key":"68132_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137 (2008).","journal-title":"Genome Biol"},{"key":"68132_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.585","volume":"2","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Exploring Epigenomic Datasets by ChIPseeker. Curr Protoc 2, e585 (2022).","journal-title":"Curr Protoc"},{"key":"68132_CR93","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"68132_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-3-r16","volume":"13","author":"Z Shao","year":"2012","unstructured":"Shao, Z., Zhang, Y., Yuan, G. C., Orkin, S. H. & Waxman, D. J. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol 13, R16 (2012).","journal-title":"Genome Biol"},{"key":"68132_CR95","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545\u201315550 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"68132_CR96","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res"},{"key":"68132_CR97","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/nprot.2017.124","volume":"12","author":"J Ernst","year":"2017","unstructured":"Ernst, J. & Kellis, M. Chromatin-state discovery and genome annotation with ChromHMM. Nat Protoc 12, 2478\u20132492 (2017).","journal-title":"Nat Protoc"},{"key":"68132_CR98","first-page":"1438","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen, Y., Lun, A. T. & Smyth, G. K. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res 5, 1438 (2016).","journal-title":"F1000Res"},{"key":"68132_CR99","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s43018-023-00620-0","volume":"4","author":"S Goswami","year":"2023","unstructured":"Goswami, S. et al. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nat Cancer 4, 1455\u20131473 (2023).","journal-title":"Nat Cancer"},{"key":"68132_CR100","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68132-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:03:22Z","timestamp":1770300202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68132-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68132"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68132-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1382"}}